INTRODUCTION
When I finished my formal pathology training in 1972, the word apoptosis did not exist. I had learned the word necrobiosis, which my medical dictionary of that vintage (20) defined as &dquo;physiologic death of a cell or group of cells, in contrast to necrosis or pathologic death of cells.&dquo; Necrosis was defined as &dquo;pathologic death of a cell or group of cells in contact with living cells.&dquo; These concepts were easy to understand. Necrobiosis was the process that maintained a normal rate of cell turnover in a tissue or organ (although it was seldom recognized in practice). Dead cells beyond the number needed for normal cell turnover were necrotic and signaled an abnormality.
In the 1960s, Dr. Benjamin Trump and his associates defined the stages that lethally injured cells pass through on their way to necrosis (26) (27) (28) (29) . We learned about high-amplitude swelling, flocculent densities, calcium fluxes, and loss of membrane integrity. In 1972, Kerr, Wyllie, and Currie (16) coined the term apoptosis to describe a different process of cell death that in some cases fulfilled the functional definition of necrobiosis. They rejected the term necrobiosis for this process, however, because it was a theoretical phenomenon that lacked defined morphological criteria and because it was sometimes used for other phenomena including degenerated collagen in the dermis (24, 34) . For many years after its original description, the concept of apoptosis languished, researched by few and discussed by only slightly more. Apoptosis and its corollary, programmed cell death, finally made their way into the scientific mainstream in the late 1980s. Discussions of apoptosis really picked up in intensity, both in frequency and in passion, about 3 or 4 years ago. During this period I observed that many pathologists, including myself, were confused by the debate. The fact that confusion still exists among pathologists was confirmed in a recent editorial (7) by Emmanuel Farber, who said, ... there is no field of basic cell biology and cell pathology that is more confusing and more unintelligible than is the area of apoptosis versus necrosis.
[emphasis in original]
A very recent article by Drs. Guido Majno and Isabelle Joris (19) provides an outstanding historical account of the development of the current situation. In this article, they propose 2 new terms, apoptotic necrosis and oncosis, for concepts that may help clarify certain aspects of the processes; but at least one of the terms may be troublesome. More about that later.
Presently we are aware of 3 major types of cell death: necrosis, apoptosis, and terminal differentiation (such as in keratinocytes of the skin). It has been pointed out, however, that there are types of cell death that do not fit neatly into these categories (19, 33) . Thus, additional modes and terms may emerge in the future. This commentary principally addresses apoptosis as compared to necrosis. A recent review article (6) and a discussion with its author, Dr. George Corcoran, spurred me to explore the literature on this important topic. This process clarified several of my misconceptions and stimulated my thinking. I would like to share some of my realizations with you.
APOPTOSIS AND NECROSIS
Periodically in the literature since 1972, the phenomena of necrosis and apoptosis have been compared in detail (references 5-7, 15, 19, 24, 25 , and 34 are representative). Briefly, the distinctions are as follows. Necrosis typically involves foci or areas containing numerous contiguous cells. Cells undergoing necrosis swell (especially noticeable in the mitochondria and endoplasmic reticulum) as they lose the ability to maintain fluid and electrolyte balance. Chromatin in the nucleus clumps irregularly (pyknosis) or dissolves (karyolysis). Eventually the cell membrane loses its integrity and the cell ruptures. This process may take many hours to complete, is energy-independent, and elicits inflammation. Apoptosis, in contrast, typically involves individual cells or small clusters of cells. In this process, the cells shrink, become more electron-dense, and lose intimate contact with adjacent cells. Chromatin becomes clumped at the margins of the nucleus, giving the histological picture of karyorhexis. Normal mitochondrial morphology and function are maintained. The cell eventually fragments into membrane-bound &dquo;apoptotic bodies&dquo; that contain varying mixtures of organelles, some of which include nuclear fragments. These bodies are phagocytosed either by adjacent epithelial cells (in epithelial organs) or by resident tissue macrophages or are sloughed from an epithelial surface. Ultimately, the apoptotic bodies undergo changes that ultrastructurally resemble classic necrosis, where the mitochondria swell and membranes break down. The process may be completed in 1-4 hr (exclusive of apoptotic body digestion), is energy-dependent, and does not elicit inflammation.
SAY IT AS YOU WILL
The pronunciation of apoptosis is, perhaps, a trivial matter, but it has been a matter of some debate.
The following footnote appeared in the 1972 Kerr, Wyllie, and Currie article:
The word &dquo;apoptosis&dquo; is used in Greek to describe the &dquo;dropping ofr' or &dquo;falling off&dquo; of petals from flowers, or leaves from trees. To show the derivation clearly, we propose that the stress should be on the penultimate syllable, the second half of the word being pronounced like &dquo;ptosis&dquo; (with the &dquo;p&dquo; silent), which comes from the same root &dquo;to fall,&dquo; and is already used to describe drooping of the upper eyelid.
Nevertheless, many of you say &dquo;a pop to sis,&dquo; and this has reasoned support from Dr. John Funder (8) , who points out that we do pronounce the middle p in other Greek-derived words such as helicopter.
APOPTOSIS AND NECROSIS ARE

MORPHOLOGIC DIAGNOSES
The increased interest in apoptosis in the late 1980s corresponded to the development of biochemical techniques like DNA electrophoresis that helped dissect its mechanisms and of cytochemical techniques that aid in its detection. In some models of apoptosis, activated intracellular endonucleases disrupt DNA at nucleosomes, yielding doublestranded fragments in lengths that are multiples of about 180 base pairs (33) . These fragments show a so-called laddering pattern on gel electrophoresis (3). In necrosis, on the other hand, DNA is typically disrupted randomly, yielding single-strand fragments of varying length that show a diffuse electrophoretic pattern. More recently, techniques that identify double-and single-strand breaks in nuclei in histological sections have accelerated interest in cell death mechanisms among pathologists (9, 11, 30) . The widespread use of these biochemical and histological techniques and the prominence they receive in lectures and publications led me to believe that they, or other specialized techniques, were necessary to confirm the diagnosis of apoptosis. But this is not so. Apoptosis and necrosis are defined by their morphological changes. None of the reviewers over the last 20 years has suggested that biochemical or histochemical techniques are needed to make the diagnosis. Consider the following from Dr. George Corcoran (6) , who is a biochemical toxicologist, not a pathologist:
[B]ecause apoptosis was originally defined by morphologic criteria, morphology at the cell and ultrastructural level remains the gold standard for documentation of apoptosis. [emphasis added] Thus, as morphologists the distinction between these 2 types of cell death currently resides in our hands. The specialized techniques are helpful in understanding and detecting the phenomena but are not needed to distinguish between them. The search for specific biochemical markers of apoptosis continues, however. Recently, such research efforts have focused on genes that can either stimulate apoptosis, like p53, or inhibit it, like bcl-2 (6, 15, 25) .
APOPTOSIS IS NOT SYNONYMOUS WITH &dquo;PROGRAMMED CELL DEATH&dquo;
Originally, the term programmed cell death was used by developmental biologists when referring to cells &dquo;programmed&dquo; to die at precise times and locations in an embryo or fetus allowing its normal development or during metamorphosis in amphibians, invertebrates, and so forth. One can expand this definition to include the physiological death of cells in adult organisms that allows a steady state of cell kinetics to be maintained. The latter is our old friend necrobiosis. These physiological occurrences of programmed cell death are usually (but not always) associated with the morphological changes that define apoptosis.
Apoptosis can also occur in cells injured by toxins, viruses, or cell-mediated cytotoxicity (1, 16, 24, 34) , situations where death of the cells is clearly abnormal, that is, is not a part of normal development. Unfortunately, in my opinion, some authors began to use the term &dquo;programmed cell death&dquo; in reference to the cascade of intracellular events that, once triggered, leads to apoptosis whether in physiological or pathological settings. Thus, there are 2 different definitions of programmed cell death, one referring to cells that are programmed to die in a developmental or homeostatic setting (some of which, like keratinocytes, do not exhibit apoptosis) and the other referring to the molecular &dquo;program&dquo; that initiates apoptosis. The use of these 2 different definitions grew insidiously until the terms became so confusing that the top researchers in the field (2) published a statement calling for the elimination or avoidance of this and other related terms, such as controlled cell death and cell suicided Despite this call, the use of &dquo;programmed cell death&dquo; outside the context of developmental biology persists (14) as does cell suicide (14, 19) . As readers, we must be specifically aware that the term programmed cell death may be used differently by different authors. It behooves us to read carefully and critically to decipher which definition is being used in a particular situation.
IT DOESN'T HAVE TO BE ONE OR THE OTHER, IT CAN BE BOTH Differences of opinion (dare I say arguments?) have occurred among well-qualified pathologists about whether a given treatment-related lesion represents apoptosis or necrosis. An underlying assumption in some of these misunderstandings is that the induced injury must be either one or the other.
That may be true for any individual cell, but it is not necessarily true for a tissue or organ as a whole. In fact, beginning with the original description of apoptosis in 1972, numerous examples have been cited of simultaneous apoptosis and necrosis in a given tissue induced by a common insult (1, 5, 16, 17, 24) . Furthermore, apoptosis and/or necrosis may be induced by different dosages of a xenobiotic or at different stages of lesion development (12, 13, 17, 21, 22) . These latter points have not been sufficiently emphasized. Because electrophoresis of DNA requires the use of homogenized tissue, other methods were needed to detect DNA breaks in intact cells and/or histological sections. Three different methods were developed independently in 1992-1993 (9, 1l, 30) . These techniques use various DNA polymerases to insert labeled nucleotides at strand breaks and then use chromatic developers to reveal the labels. The different polymerases label different types of strand breaks (such as with or without a complementary template; in the body of the molecule or at the ends) and so may detect somewhat different kinds of DNA injury (4). The terminology surrounding these techniques is at least as confusing as programmed cell death. Depending on the enzyme and author, the techniques may be called in situ end labeling (30) , nick translation (10, 11, 23) , nick end labeling (9) or in situ tailing (10) . The names are intended to connote the type of DNA break or location of nucleotide insertion, but beware-different papers (23 versus 30, for example) or purveyors of labeling kits may use different terms for the same technique or the same term for different techniques. Read the fine print! The use of terminal deoxynucleotidyl transferase (TDT) for labeling apoptotic cells was described by Gavrieli et al (9) , who used the acronym TUNEL (for TDT-mediated dUTP-biotin nick end labeling).
TDT is purportedly the enzyme of choice for marking apoptosis because it adds nucleotides without the use of a complementary DNA template. A template is absent at the ends of the double-stranded internucleosomal fragments, which are the source of the apoptotic DNA laddering pattern on electrophoresis. Some authors have expressed unqualified acceptance of this method as being specific for apoptosis ( 19) , but review of the original article does not support this claim. Gavrieli and coworkers did not test their technique on models of necrosis, and they made no claim of its specificity for apoptosis. In fact, a careful reading of their article shows just the opposite. They used the technique on normal tissues and found positively stained cells at sites where programmed cell death would be expected, as at the tips of intestinal villi. They state,
The results demonstrate that in many of these examples, where traditional criteria of apoptosis are missing, the topographical arrangement of nuclei labeled for DNA breaks by TUNEL is in perfect agreement with the expected location of PCD. The accompanying photomicrographs (Fig. 1 ) illustrate a focus of necrosis in which the cells have been positively stained by the TUNEL technique.
In an attempt to distinguish apoptosis from necrosis in certain experimental systems, Gold et al (10) used a combination of DNA labeling techniques that employed TDT and DNA polymerase I. This combination allowed the 2 forms of cell death to be distinguished in the early stages, but in later stages, that is, 24-48 hr after the stimulus, they found considerable overlap of staining. They concluded that the final interpretation required evaluation of nuclear morphology. In a toxicity study, where cell death has been induced by a xenobiotic, the process will often be more than 24 hr old by the time of tissue collection. In multidose studies, affected cells are almost certain to reflect differing stages of cumulative injury. For our purposes, therefore, the cytochemical techniques cannot, by themselves, be relied upon to distinguish whether the toxic process is apoptosis or necrosis. Traditional histological assessment is required, and electron microscopy is the most definitive technique. Although the in situ DNA labeling techniques are not specific for apoptosis versus necrosis, they are useful for locating dying cells, which are sometimes difficult to discern on hematoxylin and eosin-stained slides and for quantifying them by automated processes.
A POTENTIAL NEW CONTROVERSY
Majno and Joris point out that the term necrosis is historically regarded as the presence of dead cells or tissues, not the process by which they died (remember the old dictionary definition of necrosis).
They accept the term apoptosis to describe the process of cell death that proceeds with shrinkage and the other associated changes described by Kerr, Wyllie, and Currie. They also note that there is no comparable name for the type of prelethal cell injury characterized by swelling and the associated changes described by Trump and his associates, and which can ultimately result in necrosis. Majno and Joris coined the term &dquo;oncosis&dquo; (from the Greek for swelling) for that process. Because apoptotic bodies and their constituent organelles eventually swell and rupture like necrotic cells, they conclude that the end result of both apoptosis and oncosis may be called necrosis. To allow the processes to be distinguished, they propose the term apoptotic necrosis as a parallel to ischemic necrosis, toxic necrosis, and so forth. In most cases, however, apoptotic necrosis will only be recognized by electron microscopy.
Majno and Joris's proposals have a certain appeal in that they allow us once again to conclude that a dead cell is necrotic regardless of mechanism. On the other hand, the term oncosis will present toxicologic pathologists with a disturbing dilemma because of its obvious potential for confusion with words referring to cancer. While &dquo;oncosis&dquo; might someday become clear to pathologists, I doubt the distinction between this term and similar-sounding terms relating to cancer will ever be appreciated by the public and press (that are often, sadly, so scientifically illiterate and vulnerable to sensationalism). Who among us would want to report that a product under development is capable of causing oncosis? Would regulatory agencies without resident pathologists understand it?
SOME RECOMMENDATIONS
In an earlier section, I noted the confusion that arises when some authors equate apoptosis with programmed cell death. To avoid this confusion, I have found it helpful to divide apoptosis, conceptually, into 3 situational subcategories, namely, physiological apoptosis, toxic apoptosis, and compensatory apoptosis. I propose these categories as concepts only, not as diagnostic terms, because they overlap and require at least presumptive knowledge of etiology. Physiological apoptosis comprises that which occurs normally in developing organisms and in the adult organism to maintain a normal steady state of cell turnover (thus encompassing some forms of programmed cell death). Toxic apoptosis comprises that which has been induced or increased in frequency by a pathogenic stimulus, be it a xenobiotic, a microbe, hypoxia, or whatever. Examples familiar to us include &dquo;single cell necrosis&dquo; in the liver, neuronal &dquo;necrosis&dquo; in the central nervous system (shrunken deeply eosinophilic neurons that do not elicit an inflammatory response), or the massive death of thymic lymphocytes in animals subjected to severe stress (18) . By current morphologic definition it would be more appropriate to call these cells apoptotic rather than necrotic. Compensatory apoptosis comprises that which is increased in frequency to compensate for an abnormally increased rate of cell turnover. This may occur in hyperplastic or neoplastic tissues, or when organs atrophy after a reduction in trophic stimulation (such as the prostate after castration or the liver after phenobarbital withdrawal), or in lymphoid follicles responding to antigenic stimulation (tingible bodies).
When considering the level of apoptosis seen in a given tissue section, a caveat is needed: The level of apoptosis induced by an ongoing stimulus may be underestimated because the process proceeds so rapidly (and debris is cleared so quickly) that only a small portion of triggered cells will be recognizable at any given moment (16, 34) . This contrasts sharply with some forms of necrosis where a large lesion may be recognizable for weeks after its origination.
We all know that authors of scientific articles choose the best examples of a phenomenon to illustrate findings and emphasize ideas. I am sure that the histological photomicrographs, electron micrographs, and schematic drawings that have been used to describe and contrast apoptosis and necrosis were carefully selected to make specific points. They reflect the author's interpretation of the data and present the audience with an idealized view of nature.
Those of us in toxicologic pathology, whose responsibility is to interpret findings in a toxicity study and to commit these findings to an incidence table in black and white, know that in real life this idealized picture is often blurred. We can easily recognize coagulative necrosis induced by a test article when it involves many contiguous cells such as in the liver or in papillary muscles of the heart. In these cases, no one would argue about making a diagnosis of necrosis. At the other end of the spectrum, when we encounter what is clearly apoptosis in supraphysiological proportions, we should not be reluctant to make this diagnosis.
But how should we treat findings that are not as definitive as those already mentioned? For example, I have seen a compound-related liver lesion where some cells were clearly apoptotic but others in the same section had some of the characteristics of necrosis. These cells were swollen and had pyknotic or karyolytic nuclei, yet were individualized and did not elicit inflammation. In such a situation, electron microscopy could be used to clarify whether one or both processes are at work. If it were determined that both apoptosis and necrosis of individual cells were occurring, or if the process could not be clearly defined, I would suggest using the term &dquo;individual cell death&dquo; as a diagnosis, accompanied by a detailed description in the text of the report. What about situations where apoptotic cells are present near the periphery of necrotic foci? Should we be splitters and independently grade both the apoptosis and necrosis or lumpers under the assumption that the 2 faces of cell death reflect a continuum caused by a single agent? Such questions cannot be answered succinctly. There is no one correct answer. We know from our diverse professional experiences that histological changes such as these are often part of a continuum. How these changes are perceived, interpreted, and reported will depend on where in the continuum they fall, as well as the nature of the inducing agent and the treatment protocol. Such ambiguities and variables are what makes toxicologic pathology partly an art and why peer reviews have become a necessity.
Apoptosis (and, for that matter, necrosis) has somewhat different appearances depending on the organ or substructure involved (e.g., gut. thymus, liver, kidney, brain). Despite the published descriptions, it is not always easy to distinguish apoptosis from necrosis. At this time. there are no guidelines to help toxicologic pathologists recognize and report the different forms of cell death in specific organs. The Society of Toxicologic Pathologists' program to standardize lesion nomenclature through the Guides for Toxicologic Pathology seems a natural venue to address this problem. I suggest that the Society form a new committee under this program to study this important and controversial issue and make recommendations. The Society should also cooperate with Majno and Joris to find an alternative to the potentially troublesome word oncosis.
In this commentary, I have briefly touched on the definition and mechanisms of apoptosis and stressed the ability to detect and/or recognize increased cell death in tissues. We should also be aware, however, that decreased apoptosis may be an important factor in tumor promotion and will likely be the subject of much future research and discussion (14, 31 ) .
